Figure 4

Prevalence of erythromycin resistance and of macrolide resistance phenotypes among isolates recovered from invasive infections in Portugal during 2000–2015. The numbers below each period represent the total number of iGAS isolates recovered. Data from 2000–2005 and 2006–2009 was previously published^17,18.